Neurologian yksikkö
Department of Neurology

Julkaisut 1998
Publications 1998

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aura J et al. Tetrahydroaminoacridine and D-cycloserine stimulate acquisition of water maze spatial navigation in aged rats.
2 Barnett HJM et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.
3 Björklund M et al. Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies.
4 Chauhan A et al. Aggregation of amyloid beta-protein as function of age and apolipoprotein E in normal and Alzheimer`s serum.
5 Cho YH et al. Abnormal hippocampal spatial representations in alfaCaMKII T286A and CREBalfa delta- Mice.
6 European Carotid Surgery Trialists´ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).
7 Hacke W et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).
8 Helisalmi S. Molecular Genetics of Alzheimer´s Disease . With Special Emphasis on Presenilin, Amyloid Beta Precursor Protein and Apolipoprotein E Genes.
9 Hiltunen M et al. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer´s disease patients.
10 Ikonen S et al. Apamin improves spatial navication in medial septal-lesioned mice.
11 Insausti R et al. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices.
12 Jalanko A et al. Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
13 Juottonen K. MRI Volumes of the Entorhinal, Perirhinal and Temporopolar Cortices in Normal Aging and in Alzheimer´s Disease.
14 Juottonen K et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer`s disease.
15 Juottonen K et al. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer`s disease carrying the apolipoprotein E epsilon4 allele.
16 Korhonen P et al. Expression of transcriptional repressor protein mSin3A but not mSin3B is induced during neuronal apoptosis.
17 Kälviäinen R et al. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy.
18 Laakso MP et al. MRI of the hippocampus in Alzheimer`s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.
19 Lehtovirta M et al. Longitudinal SPECT study in Alzheimer`s disease: relation to apolipoprotein E polymorphism.
20 Mattila KM et al. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer´s disease.
21 Mehta PD et al. Biological test to confirm the diagnosis of Alzheimer`s disease in cognitively impaired patients. A fact or fiction?
22 Miettinen R et al. Hippocampal damage after injection of kainic acid into the rat entorhinal cortex.
23 Mikkonen M et al. Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex.
24 Murros K. Päänsärky.
25 Murros K. Jännityspäänsärky.
26 Murros K. Migreeni.
27 Murros K. Kasvojen alueen neuralgiat.
28 Pirttilä T et al. Alzheimerin taudin täsmähoito - haaste terveydenhuollolle.
29 Pirttilä T et al. Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer`s disease.
30 Pitkänen A et al. Amygdala damage in experimental and human temporal lobe epilepsy.
31 Puoliväli J et al. Muscarinic M1 and M2 receptor subtype selective drugs modulate neocortical EEG via thalamus.
32 Puoliväli J et al. Oxotremorine suppresses thalamocortical oscillations via thalamic muscarinic acetylcholine receptors.
33 Puranen J et al. Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
34 Riekkinen M et al. Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson`s disease.
35 Riekkinen M et al. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
36 Riekkinen P Jr et al. Tetrahydroaminoacridine, a cholinesterase inhibitor, and d-cycloserine, a partial NMDA receptor-associated glycine site agonist, enhances acguisition of spatial navication.
37 Riekkinen P Jr et al. Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson`s disease patients.
38 Riekkinen P Jr et al. Animal models in the development of symptomatic and preventive drug therapies for Alzheimer´s disease.
39 Roschier M et al. Expression of seizure-related PTZ-17 is induced by potassium deprivation in cerebellar granule cells.
40 Ruotsalainen S et al. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
41 Salmenperä T et al. Hippocampal damage caused by seizures in temporal lobe epilepsy.
42 Salminen A et al. Neuronal apoptosis induced by histone deacetylase inhibitors.
43 Sivenius J et al. Aivohalvausten ilmaantuvuuden ja aivohalvauskuolleisuuden muutokset kymmenen vuoden aikana FINMONICA-tutkimuksessa.
44 Soininen HS, Riekkinen PJ Sr. ApoE and memory in Alzheimer´s disease.
45 Soininen HS, Scheltens P. Early diagnostic indices for the prevention of Alzheimer´s disease.
46 Solovyan V et al. Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells.
47 Sorvari H et al. Calretinin-immunoreactive terminals make synapses on calbindin D28k-immunoreactive neurons in the lateral nucleus of the human amygdala.
48 Tanila H. Unique features in the processing of spatial information by the aged hippocampus as shown by place cell recording studies: a response to Peter Rapp´s commentary "Representational organization in the aged hippocampus".
49 Tanila H et al. Cognitive changes in mice following moderate MPTP exposure.
50 Tapiola T et al. Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer´s disease.
51 Tapiola T et al. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
52 The Ronald and Nancy Reagan Research Institute of the Alzheimer's ... Consensus report of the working group on: Molecular and biochemical markers of Alzheimer´s disease.
53 Vanhanen M et al. Cognitive function in an elderly population with persistent impaired glucose tolerance.
54 Vanhanen M, Soininen H. Glucose intolerance, cognitive impairment and Alzheimer´s disease.
55 Vanninen R et al. Subclinical cerebral complications after coronary artery bypass grafting.
56 Wisniewski HM et al. Etiology and neuropathogenesis of Alzheimer`s disease.
Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008